InsiderClue
Insiders · Profile

Mandel-Brehm Josh

Chief Executive Officer at Camp4 Therapeutics. Filing since 11 Sep 2025. CIK 0001927058

Company
Date
Role
Action
Shares
Amount
Of holding
CAMP Camp4 Therapeutics Corp
3 Aug 2026
Chief Executive Officer
Bought
6,551
$10.81K
2.4%
CAMP Camp4 Therapeutics Corp
11 Sep 2025
Chief Executive Officer
Bought
6,060
$10.00K
2.2%
2 decisions on file.